Cosford; Nicholas David Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cosford; Nicholas David Peter.The latest application filed is for "inhibitor of apoptosis protein (iap) antagonists".

Company Profile

10.10.12

Cosford; Nicholas David Peter - San Diego CA
Cosford; Nicholas David Peter - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof Grant 11,447,453 - Cosford , et al. September 20, 2	2022-09-20
Inhibitor of Apoptosis Protein (IAP) Antagonists App 20220119444 - COSFORD; Nicholas David Peter ; et al.	2022-04-21
Inhibitor of apoptosis protein (IAP) antagonists Grant 11,111,270 - Cosford , et al. September 7, 2	2021-09-07
Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy Grant 10,864,217 - Pache , et al. December 15, 2	2020-12-15
Metabotropic Glutamate Receptor Negative Allosteric Modulators (nams) And Uses Thereof App 20200347021 - COSFORD; Nicholas David Peter ; et al.	2020-11-05
Inhibitor of Apoptosis Protein (IAP) Antagonists App 20200317731 - COSFORD; Nicholas David Peter ; et al.	2020-10-08
Use of Inhibitor of Apoptosis Protein (IAP) Antagonists in HIV Therapy App 20200121693 - PACHE; Lars ; et al.	2020-04-23
Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof Grant 10,597,367 - Cosford , et al.	2020-03-24
Inhibitor of apoptosis protein (IAP) antagonists Grant 10,544,188 - Cosford , et al. Ja	2020-01-28
Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy Grant 10,300,074 - Pache , et al.	2019-05-28
Inhibitor of Apoptosis Protein (IAP) Antagonists App 20190135861 - COSFORD; Nicholas David Peter ; et al.	2019-05-09
Metabotropic Glutamate Receptor Negative Allosteric Modulators (nams) And Uses Thereof App 20190016715 - COSFORD; Nicholas David Peter ; et al.	2019-01-17
Inhibitor of apoptosis protein (IAP) antagonists Grant 10,047,119 - Cosford , et al. August 14, 2	2018-08-14
Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof Grant 9,969,726 - Cosford , et al. May 15, 2	2018-05-15
Metabotropic Glutamate Receptor Negative Allosteric Modulators (NAMS) and Uses Thereof App 20170217951 - COSFORD; Nicholas David Peter ; et al.	2017-08-03
Use of Inhibitor of Apoptosis Protein (IAP) Antagonists in HIV Therapy App 20170196879 - PACHE; Lars ; et al.	2017-07-13
Inhibitor of Apoptosis Protein (IAP) Antagonists App 20170081362 - COSFORD; Nicholas David Peter ; et al.	2017-03-23
Inhibitor of apoptosis protein (IAP) antagonists Grant 9,546,174 - Cosford , et al. January 17, 2	2017-01-17
Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same App 20090105240 - Mustelin; Tomas ; et al.	2009-04-23
Alkyne derivatives as tracers for metabotropic glutamate receptor binding App 20070060618 - Cosford; Nicholas David Peter ; et al.	2007-03-15
Thiazolyl(pyridyl)ethyne compounds Grant 6,774,138 - Cosford , et al. August 10, 2	2004-08-10
Thiazolyl(pyridyl)ethyne compounds App 20030055247 - Cosford, Nicholas David Peter ; et al.	2003-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.